Cargando…
Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients
The functional abnormality of circadian regulation genes is involved in the development and progression of hepatocellular carcinoma (HCC). However, the association between functional single nucleotide polymorphisms (SNPs) in circadian gene NPAS2 and the overall survival of HCC patients treated with...
Autores principales: | Yuan, Peng, Wang, Shen, Zhou, Feng, Wan, Shaogui, Yang, Yefa, Huang, Xiaojun, Zhang, Zhaohui, Zhu, Yong, Zhang, Hongxin, Xing, Jinliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317913/ https://www.ncbi.nlm.nih.gov/pubmed/24754267 http://dx.doi.org/10.1111/cas.12428 |
Ejemplares similares
-
NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A
por: Yuan, Peng, et al.
Publicado: (2017) -
Genetic Variants in the EPCAM Gene Is Associated with the Prognosis of Transarterial Chemoembolization Treated Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Yu, Xiaohe, et al.
Publicado: (2014) -
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma
por: Yin, Xin, et al.
Publicado: (2014) -
Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma
por: Yang, De-jun, et al.
Publicado: (2016) -
Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Nhu, Quan M, et al.
Publicado: (2016)